SCHEMBL27620693

SCHEMBL27620693

O=C1NCC(C(=O)Cl)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29014782 1.00
SCHEMBL4409122 0.80
SCHEMBL6601988 0.80
SCHEMBL23227487 0.78
SCHEMBL18306102 0.74 CHRNB2 (0.36)
SCHEMBL18305953 0.74 CHRNB2 (0.36)
SCHEMBL28693616 0.74 USP2 (0.33)
SCHEMBL17585530 0.72
SCHEMBL14827980 0.72
SCHEMBL3144405 0.71 USP2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109419802-B Compounds having dopamine D3 receptor modulating activity and uses thereof 中国人民解放军军事医学科学院毒物药物研究所(CN) 2023-01-13 CN disclosed
CN-102264733-A novel dopamine D3 receptor ligand, preparation method and medical application thereof 2011-11-30 CN disclosed
CN-1639135-A N-aryl-2-oxazolidinone-5-amides and derivatives thereof and their use as antibacterial agents UPJOHN CO (US) 2005-07-13 CN disclosed